Ornithine decarboxylase is the initial and rate-limiting enzyme in the polyamine biosynthetic pathway. Polyamines are found in all mammalian cells and are required for cell growth. We previously demonstrated that N-hydroxyarginine and nitric oxide inhibit tumor cell proliferation by inhibiting arginase and ornithine decarboxylase, respectively, and, therefore, polyamine synthesis. In addition, we showed that nitric oxide inhibits purified ornithine decarboxylase by S-nitrosylation. Herein, we provide evidence for the chemical mechanism by which nitric oxide and S-nitrosothiols react with cysteine residues in ornithine decarboxylase to form an S-nitrosothiol(s) on the protein. The NONOate nitric oxide donor agent DEA/NO acts through an oxygen-dependent mechanism leading to formation of the nitrosating agents N 2 O 3 and/or N 2 O 4 . SNitrosoglutathione inhibits ornithine decarboxylase by an oxygen-independent mechanism, likely by S-transnitrosation. In addition, we provide evidence for the Snitrosylation of four cysteine residues per ornithine decarboxylase monomer including cysteine 360, which is critical for enzyme activity. Finally, S-nitrosylated ornithine decarboxylase was isolated from intact cells treated with nitric oxide, suggesting that nitric oxide may regulate ornithine decarboxylase activity by S-nitrosylation in vivo.
INTRODUCTION
Ornithine decarboxylase (ODC), the rate-limiting enzyme in putrescine synthesis, catalyzes the conversion of ornithine to putrescine, and is essential for polyamine synthesis in mammalian cells. In spite of the fact that polyamines are present in all mammalian cells, extensive research efforts have failed to fully elucidate their physiological functions. That polyamines are required, however, in order to maintain cell growth and function is clearly established (1) (2) (3) . Many early studies indicate that polyamine synthesis is enhanced during growth and that growth-promoting stimuli lead to increases in polyamine biosynthesis. Direct evidence for this has been provided by experiments in which polyamine synthesis was prevented in mammalian cells in culture by mutations to key enzymes (such as ODC) or by the application of enzyme inhibitors (2, (4) (5) (6) . This led to cessation of growth unless exogenous polyamines were provided.
More recent studies have shown that polyamines stimulate DNA synthesis and increase the transcription of growth related genes (7) (8) .
Increases in nitric oxide synthase activity and addition of exogenous nitric oxide (NO) have been widely recognized to result in inhibition of cell proliferation (11) (12) (13) (14) (15) . In many of these studies, cyclic-3',5'-guanosine monophosphate (cyclic GMP) did not account for the cytostatic effect of NO, and the evidence for cyclic GMP-dependent inhibition of cell proliferation is at best inconsistent and indirect. We have consistently observed cyclic 4 rat aortic smooth muscle cells was reversed by the addition of exogenous polyamines but not by ornithine, suggesting that NO inhibited ODC.
ODC is a homodimer and forms two active sites at the interface between the two monomers. It contains two cysteine residues (C70 and C360) in each active site (19) and a total of 12 cysteine residues per monomer. C360 is required for enzymatic activity, as mutating C360 to alanine reduces enzyme activity by 98% (20, 21) . Nitrogen oxide species have been shown to readily react with both protein and low molecular weight thiols to form S-nitrosothiols (22, 23 ). An increasing number of proteins such as albumin, p21
ras , caspase 3, glyceraldehyde 3-phosphate dehydrogenase, hemoglobin, and NFκ-B as well as the low molecular weight thiols, cysteine and glutathione, have been found to be S-nitrosylated in vivo (22, (24) (25) (26) (27) (28) . In addition, many proteins, including ODC, have been shown to be S-nitrosylated in vitro (29) .
The objective of this study was three-fold: (1) to provide further evidence for the Snitrosylation of ODC and the chemical mechanism by which it is S-nitrosylated, (2) to determine if C360, the critical cysteine residue in the active site of ODC, is S-nitrosylated, and (3) to determine if ODC is S-nitrosylated in intact cells.
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Saturated NO solutions were prepared by bubbling pure NO gas through water under anaerobic conditions.
Preparation of Plasmids: pHIS-ODC was prepared as previously described (29) . The resulting plasmid codes for an ODC protein with the following amino terminus:
MRGSHHHHHHGS. For the pHIS-ODC C360A mutant, cysteine 360 was mutated to alanine in pGEM-ODC using the chameleon mutagenesis kit (Stratagene, La Jolla, CA).
The pGEM construct was then digested with Sph I and Sal I, and the fragment containing the mutation was isolated and inserted into pHIS-ODC. pCMVZeo-ODC was prepared as previously described (32 ). NO, in the gas phase, is then carried through a cold trap (-75ºC) and swept into the chemiluminescence detector.
Chemiluminescence was performed as previously described (15) . Authentic GSNO was used to make a standard curve and the concentration of the GSNO stock solution was confirmed by spectrophotometry. NO release from GSNO was not detectable when the light source was off. leupeptin, 1 µg/ml pepstatin, and 1 µg/ml aprotinin. 20 µg total protein from each sample were subjected to SDS-polyacrylamide (10%) gel electrophoresis and proteins were transferred to a nitrocellulose membrane. The membrane was then probed with rabbit anti-ODC antiserum (0.5 µg/ml) followed by goat anti-rabbit horseradish peroxidase- were then dissociated from the beads with 500 µl of 100 mM glycine buffer (pH 2.5).
Determination of Protein
The protein G-Sepharose beads were removed by centrifugation and the supernatant was kept on ice prior to analysis.
RESULTS
The effects of NO donor agents on ODC activity-We previously reported that NO donor agents inhibit purified ODC via S-nitrosylation (29) . We show here that the NO donor agents GSNO and DEA/NO inhibit purified ODC in a concentration-dependent manner under aerobic conditions ( Fig.1) . Furthermore, the inhibition of ODC by both NO donor agents was reversible by addition of 2.5 mM DTT and to a lesser extent by 5 mM glutathione (GSH), providing evidence that NO acts to inhibit the enzyme by Snitrosylation ( Fig.1 ).
GSNO was more potent than DEA/NO as an inhibitor of ODC despite the fact that GSNO does not readily release NO. DEA/NO, on the other hand, has a half-life of NO release of approximately 2 minutes. This led us to investigate the mechanism of Snitrosylation by the two NO donor agents. We set forth the hypothesis that GSNO acts by participating in an S-transnitrosation reaction with cysteine residue(s) on ODC, whereas DEA/NO likely acts through the reaction of NO with O 2 to form N 2 O 3 and N 2 O 4 , both of which are nitrosating agents (Fig.2 ).
We first tested the capacity of GSNO and DEA/NO to inhibit ODC under anaerobic conditions. According to our hypothesis, GSNO should inhibit ODC under anaerobic conditions whereas DEA/NO should not, since the formation of N 2 O 3 or N 2 O 4 from NO is oxygen-dependent. As predicted, GSNO was equipotent under aerobic and anaerobic conditions (Fig.3) . The inhibition of ODC caused by GSNO under anaerobic conditions was, like under aerobic conditions, reversible by DTT and GSH (Fig.4 ). This suggests that GSNO acts by the same mechanism under both aerobic and anaerobic conditions. DEA/NO failed to significantly inhibit ODC under anaerobic conditions at all concentrations tested ( respectively. Under anaerobic conditions, 100 µM DEA/NO in the presence of 30 µM PTIO inhibited ODC by approximately 80%, whereas DEA/NO or PTIO alone had no effect (Fig.6 ). The inhibition of ODC by the combination of DEA/NO and PTIO was reversible by the addition of DTT or GSH, again suggesting that ODC was S-nitrosylated ( Fig.7) .
Analysis of S-nitrosylated ODC by photolysis-chemiluminescence-Photolysis-
chemiluminescence is an established method for determining the S-nitrosothiol content of proteins (22) . We, therefore, developed our own apparatus to utilize photolysis-chemiluminescence to study the S-nitrosylation of ODC by NO. The present method was somewhat less sensitive than that previously described by Stamler et al. (22, 36) . This was not a limitation as we were able to repeat Stamler's earlier work showing that albumin, when in its native state, is S-nitrosylated on a single cysteine residue. 250 µl of a 100 µg/ml solution of albumin was mixed 1:1 (v/v) with a saturated NO solution and incubated for 30 min in the dark at room temperature. Excess NO was removed from the solution by purging the headspace with argon for 20 min. The sample was then analyzed by photolysis-chemiluminescence. A standard curve was prepared using authentic GSNO (Fig.8A ). The concentration of GSNO stock solution was verified by spectrophotometry. In agreement with Stamler, albumin was determined to contain 0.91 ± 0.14 mol of SNO per mol of protein (Fig.8B) . The same procedure using purified ODC and treatment of ODC with NO resulted in the S-nitrosylation of 3.89 ± 0.23 thiol residues per ODC monomer (Fig.8B) , strengthening the hypothesis that NO Snitrosylates ODC.
As a means of determining if C360 is one of the four residues in ODC S-nitrosylated by NO, C360A ODC, in which C360 is mutated to alanine, was analyzed as above.
C360A ODC was determined to contain 2.81 ± 0.17 SNO molecules per ODC monomer (Fig.8B) . This is one less SNO molecule per monomer than wild type ODC and was significantly different as determined by the Student's t-test (p<0.01).
Isolation of S-nitrosylated ODC from intact cells-Our final objective was to
determine whether S-nitrosylated ODC could be isolated from cells that had been treated with NO. ODC was overexpressed in NIH 3T3 cells by transfection with pCMVZeo-ODC. This plasmid codes for an ODC protein that is truncated at the C-terminus at amino acid residue 425. Since the C-terminus is required for ODC to be degraded by the proteasome, the truncated form of the protein is stable and can accumulate to very high levels within the cell. pCMVZeo-ODC transfected cells showed a marked increase in ODC protein as determined by Western blot analysis (Fig.9A) , and an approximate 200-fold increase in ODC activity (Fig.9B) (Fig.10 ). This suggests that in both cases there was either no S-nitrosylated ODC or that it was below the detectable limit. In pCMVZeo-ODC transfected cells immunoprecipitated with anti-ODC antibody, 36.8 ± 4.5 pmol of S-nitrosylated protein per mg of total cell protein was detected (Fig.10 ). In addition, there was no detectable S-nitrosylated ODC in immunoprecipitates from pCMVZeo-ODC transfected cells that were not treated with CysNO (data not shown).
DISCUSSION
When ODC is inactivated by the enzyme-activated, irreversible inhibitor, α-difluoromethylornithine (DFMO), a stoichiometric amount of a covalent adduct is formed with the protein, with the major site for this reaction being C360 (37) . This suggests that C360 must be located in the active site of ODC, which was recently confirmed by x-ray crystallography (19) . The importance of this residue has been established by mutation of this cysteine to serine or alanine (38) .
There is ample evidence that NO inhibits ODC. The initial evidence supporting this came from a study in which sodium nitroprusside was shown to inhibit cell proliferation by inhibiting putrescine synthesis (11) . Further evidence of this has been provided by studies in our laboratory in which inhibition of Caco-2 cell proliferation or vascular smooth muscle cell proliferation by NO was shown to be reversible by addition of excess putrescine, spermidine, or spermine, but not ornithine (15, 16 We recently demonstrated that NO donor agents inhibit purified ODC by Snitrosylation (17). In the current study, NO, in the form of GSNO or DEA/NO, inhibited ODC in a concentration-dependent manner. Inhibition of ODC by both NO donor agents was reversible by addition of DTT or GSH, supporting the hypothesis that NO inhibits ODC via S-nitrosylation of a critical cysteine residue(s) on ODC. The present data further support the hypothesis that NO and related species inhibit ODC by Snitrosylation. Photolysis chemiluminescence is an effective tool for determining not only whether a protein is S-nitrosylated but also for quantifying the number of residues modified by S-nitrosylation (22) . It combines both specificity and sensitivity, since
SNOs are photolabile and the chemiluminescence detectors used for detecting NO are both specific for NO and very sensitive. Exposure to ultraviolet light may result in the formation of NO also from nitrite, nitrosamines, and dinitrosyliron complexes and was controlled for in our experiments. Using this method we show that approximately 4 cysteine residues per ODC monomer are S-nitrosylated when the enzyme is treated with a saturated NO solution. In addition, we provide evidence that C360, which is critical for enzyme activity, is S-nitrosylated since the C360A ODC mutant is S-nitrosylated on only 3 cysteine residues.
These findings led us to investigate whether S-nitrosylated ODC could be isolated Therefore, whereas this reaction may not take place in the cell cytosol, it may be important in biological membranes.
The inhibition of ODC, by GSNO, on the other hand was independent of O 2 .
Furthermore, the enzyme inhibition caused by GSNO was equipotent in the presence and absence of oxygen and was reversible by the addition of DTT or GSH under both conditions. These data suggest that GSNO acts by the same mechanism under aerobic or anaerobic conditions. Furthermore, these data rule out the possibility that GSNO simply acts through release of NO, since NO by itself does not readily react with thiol residues.
Besides being able to release NO under the appropriate conditions, S-nitrosothiols can 
